Literature DB >> 30473991

Cellular senescence in intervertebral disc aging and degeneration.

Prashanti Patil1, Laura J Niedernhofer2, Paul D Robbins2, Joon Lee1, Gwendolyn Sowa1,3, Nam Vo1.   

Abstract

PURPOSE: Age is a major risk factor for multiple disease pathologies, including chronic back pain, which stems from age-related degenerative changes to intervertebral disc tissue. Growing evidence suggest that the change in phenotype of disc cells to a senescent phenotype may be one of the major driving forces of age-associated disc degeneration. This review discusses the known stressors that promote development of senescence in disc tissue and the underlying molecular mechanisms disc cells adopt to enable their transition to a senescent phenotype. RECENT
FINDINGS: Increased number of senescent cells have been observed with advancing age and degeneration in disc tissue. Additionally, in vitro studies have confirmed the catabolic nature of stress-induced senescent disc cells. Several factors have been shown to establish senescence via multiple different underlying mechanisms.
SUMMARY: Cellular senescence can serve as a therapeutic target to combat age-associated disc degeneration. However, whether the different stressors utilizing different signaling networks establish different kinds of senescent types in disc cells is currently unknown and warrants further investigation.

Entities:  

Keywords:  Aging; cellular senescence; intervertebral disc degeneration

Year:  2018        PMID: 30473991      PMCID: PMC6248341          DOI: 10.1007/s40610-018-0108-8

Source DB:  PubMed          Journal:  Curr Mol Biol Rep        ISSN: 2198-6428


  102 in total

1.  Classification of age-related changes in lumbar intervertebral discs: 2002 Volvo Award in basic science.

Authors:  Norbert Boos; Sabine Weissbach; Helmut Rohrbach; Christoph Weiler; Kevin F Spratt; Andreas G Nerlich
Journal:  Spine (Phila Pa 1976)       Date:  2002-12-01       Impact factor: 3.468

2.  Analysis of tissue distribution of TNF-alpha, TNF-alpha-receptors, and the activating TNF-alpha-converting enzyme suggests activation of the TNF-alpha system in the aging intervertebral disc.

Authors:  Beatrice E Bachmeier; Andreas G Nerlich; Christoph Weiler; Günther Paesold; Marianne Jochum; Norbert Boos
Journal:  Ann N Y Acad Sci       Date:  2007-01       Impact factor: 5.691

Review 3.  Stress-activated MAP kinase cascades in cellular senescence.

Authors:  Junichi Maruyama; Isao Naguro; Kohsuke Takeda; Hidenori Ichijo
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

4.  Pyrroloquinoline quinone protects nucleus pulposus cells from hydrogen peroxide-induced apoptosis by inhibiting the mitochondria-mediated pathway.

Authors:  Lianjun Yang; Zijie Rong; Mingjun Zeng; Yanlin Cao; Xumeng Gong; Lijun Lin; Yong Chen; Wei Cao; Lixin Zhu; Weiren Dong
Journal:  Eur Spine J       Date:  2014-10-28       Impact factor: 3.134

5.  ISSLS prize winner: inhibition of NF-κB activity ameliorates age-associated disc degeneration in a mouse model of accelerated aging.

Authors:  Luigi A Nasto; Hyoung-Yeon Seo; Andria R Robinson; Jeremy S Tilstra; Cheryl L Clauson; Gwendolyn A Sowa; Kevin Ngo; Qing Dong; Enrico Pola; Joon Y Lee; Laura J Niedernhofer; James D Kang; Paul D Robbins; Nam V Vo
Journal:  Spine (Phila Pa 1976)       Date:  2012-10-01       Impact factor: 3.468

Review 6.  Function and activation of NF-kappa B in the immune system.

Authors:  P A Baeuerle; T Henkel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

Review 7.  Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors.

Authors:  Judith Campisi
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

Review 8.  Aging and genome maintenance: lessons from the mouse?

Authors:  Paul Hasty; Judith Campisi; Jan Hoeijmakers; Harry van Steeg; Jan Vijg
Journal:  Science       Date:  2003-02-28       Impact factor: 47.728

Review 9.  The senescence-associated secretory phenotype: the dark side of tumor suppression.

Authors:  Jean-Philippe Coppé; Pierre-Yves Desprez; Ana Krtolica; Judith Campisi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

10.  An organ culture system to model early degenerative changes of the intervertebral disc.

Authors:  Ravi K Ponnappan; Dessislava Z Markova; Paul J D Antonio; Hallie B Murray; Alexander R Vaccaro; Irving M Shapiro; D Greg Anderson; Todd J Albert; Makarand V Risbud
Journal:  Arthritis Res Ther       Date:  2011-10-21       Impact factor: 5.156

View more
  26 in total

1.  Senotherapeutic drugs for human intervertebral disc degeneration and low back pain.

Authors:  Hosni Cherif; Daniel G Bisson; Matthew Mannarino; Oded Rabau; Jean A Ouellet; Lisbet Haglund
Journal:  Elife       Date:  2020-08-21       Impact factor: 8.140

Review 2.  Importance of Matrix Cues on Intervertebral Disc Development, Degeneration, and Regeneration.

Authors:  Matthew J Kibble; Marco Domingos; Judith A Hoyland; Stephen M Richardson
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

Review 3.  Role of Nrf2 in cell senescence regulation.

Authors:  Huan Yuan; Yan Xu; Yi Luo; Nuo-Xin Wang; Jian-Hui Xiao
Journal:  Mol Cell Biochem       Date:  2020-09-11       Impact factor: 3.396

Review 4.  Intervertebral disc degeneration and regeneration: a motion segment perspective.

Authors:  B Ashinsky; H E Smith; R L Mauck; S E Gullbrand
Journal:  Eur Cell Mater       Date:  2021-03-24       Impact factor: 3.942

Review 5.  Extracellular Vesicles as an Emerging Treatment Option for Intervertebral Disc Degeneration: Therapeutic Potential, Translational Pathways, and Regulatory Considerations.

Authors:  Tyler J DiStefano; Keti Vaso; George Danias; Henry N Chionuma; Jennifer R Weiser; James C Iatridis
Journal:  Adv Healthc Mater       Date:  2021-07-23       Impact factor: 9.933

6.  Quercetin Alleviates Intervertebral Disc Degeneration by Modulating p38 MAPK-Mediated Autophagy.

Authors:  Shuwen Zhang; Weidong Liang; Yakefu Abulizi; Tao Xu; Rui Cao; Chuanhui Xun; Jian Zhang; Weibin Sheng
Journal:  Biomed Res Int       Date:  2021-05-11       Impact factor: 3.411

7.  Targeting ATM to mitigate intervertebral disc degeneration.

Authors:  Louise E Pitcher; Alec K Wong; Paul D Robbins
Journal:  Aging (Albany NY)       Date:  2021-04-22       Impact factor: 5.682

Review 8.  Cell and Gene Therapy for Spine Regeneration: Mammalian Protein Production Platforms for Overproduction of Therapeutic Proteins and Growth Factors.

Authors:  Ali Mobasheri; Stephen M Richardson
Journal:  Neurosurg Clin N Am       Date:  2020-01       Impact factor: 2.509

Review 9.  Exosomes derived from stem cells as an emerging therapeutic strategy for intervertebral disc degeneration.

Authors:  Zhi-Lei Hu; Hai-Yin Li; Xian Chang; Yue-Yang Li; Chen-Hao Liu; Xiao-Xin Gao; Yu Zhai; Yu-Xuan Chen; Chang-Qing Li
Journal:  World J Stem Cells       Date:  2020-08-26       Impact factor: 5.326

10.  Kinsenoside ameliorates intervertebral disc degeneration through the activation of AKT-ERK1/2-Nrf2 signaling pathway.

Authors:  Yanqiu Wang; Rui Zuo; Ziwen Wang; Liwen Luo; Junlong Wu; Chao Zhang; Minghan Liu; Chunmeng Shi; Yue Zhou
Journal:  Aging (Albany NY)       Date:  2019-09-23       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.